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 February 2019 Newsletter 
 
 
FUNDING 
~ CCTS SPARK Program (Small Pilot and Research Knowledge) 
~ CCTS Small Conference Grants 
~ NEW: UMASS Lowell and M2D2 2019 $200k Challenge (Register by 02.18.19) 
~ Mentored Career Development (KL2) Award RFA LOIs Due 02.15.2019 
~ The CD2H $100k Idea Competition (Call for Proposals) Due 02.15.2019 
~ Charles A. King Trust Postdoctoral Research Fellowship Program  
~ CIMIT (Consortia for Improving Medicine with Innovation & Technology) Funding 
~ DRIVe’s EZ-BAA 
~ Growing Gene & Cell Therapy RFA Winter 2019: Invited Full Applications Due 03.22.2019 
~ Immuno-Oncology Translation Network (IOTN): Three Funding Opportunities 
~ MCCISS K12 Support and Training 
~ NCATS Funding 
~ NEW: NIH Point-of Care Technology (POCTRN) Expressions of Interest Due 03.01.2019 
~ NEW: CureAccelerator Live! Funding Opportunities Proposals Due 02.28.2019 
 
 
CCTS SPARK PROGRAM: Rolling application deadline.  This program’s priorities are to support studies 
that impact clinical care and research methodologies, support students/trainees, and provide access to 
funds to generate pilot and preliminary data for external grant submissions.  For more information, click 
on this link: https://www.umassmed.edu/ccts/funding/spark-program/ 
 
 
CCTS SMALL CONFERENCE GRANTS: Rolling application deadline.  This funding facilitates the 
development of faculty-to-faculty networks within the University system.  Click on this link for more 
information: https://umassmed.edu/ccts/funding/small-conference-grants/ 
 
 
NEW: UMASS LOWELL / M2D2 2019 $200K CHALLENGE: The $200k Challenge is an annual start-up 
competition hosted by M2D2 focused on identifying and reward disruptive companies in the medical 
technology and biotechnology industries.  Innovations that address the full range of medical device 
challenges are welcome to apply.  This year there is a particular interest in ideas that can benefit from our 
association with the BARDA DRIVe initiative.  Up to 20 finalists will be chosen to get their innovation in 
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front of MAJOR investors!  Register by February 18, 2019.  To learn more and apply, visit 
www.m2d2challenge.com.  To learn more about the BARDA DRIVe initiative, click here. 
 
 
MENTORED CAREER DEVELOPMENT (KL2) AWARD REQUEST FOR APPLICATIONS: A major goal of 
the University of Massachusetts Center for Clinical and Translational Science (UMCCTS) is to 
develop and support the next generation of leaders in clinical and translational research. Success in 
today’s complex and competitive environment requires training that is truly transdisciplinary in 
nature, encompassing the full spectrum of translational research from discovery through pre-clinical 
development and first-in-human studies to implementation science with additional continuous 
feedback to basic science research.  The KL2 Training Program combines coursework, seminars, and 
mentored research.  
 
Letters of Intent are due by February 15, 2019, 5:00pm EST.  Submit as single .DOC or .PDF with 
supporting documentation.  Email to CCTS@umassmed.edu 
 
KL2 PROGRAM / PROPOSAL Questions GRANT PREPARATION / SUBMISSION Questions 
Contact: KL2 Program Leaders 
  Dr. John Keaney (john.keaney@umassmed.edu) 
  Dr. Jeroan Allison (jeroan.allison@umassmed.edu) 
  Dr. Milagros C. Rosal (milagros.rosal@umassmed.edu) 
  Dr. Javier Irazoqui (Javier.irazoqui@umassmed.edu) 
 
Contact:  
  Dr. Nathaniel Hafer (nathaniel.hafer@umassmed.edu) 
 
 
For full information, visit: http://www.umassmed.edu/ccts/education/KL2-training-program/ 
 
 
CD2H $100K IDEA COMPETITION: The CTSA Program’s National Center for Data to Health (CD2H) is 
excited to announce the launch of the CD2H Idea Competition: an opportunity to turn your scientific 
question into a DREAM Challenge to be tackled by teams around the world.  If selected, your idea will 
receive up to a $100,000 subcontract to run the DREAM Challenge in collaboration with the CD2H.  
Deadline to submit initial proposal is February 15, 2019 (Friday).  Initial 1-to-2 page proposals must 
include a letter of support from your CTSA Hub principal investigator. Six semi-finalists will be selected 
and invited to further develop their proposals on March 8, 2019.  CD2H will announce the winner and 
award up to a $100k subcontract by May 17, 2019. 
 
Eligibility: Proposals can be submitted by any researcher, clinician, or staff member affiliated with an 
institution that has a CTSA Hub with a current UL1 award.  Sites that currently receive subcontracts from 
CD2H are not eligible. 
 
For more information and submission guidelines, click here. 
 
 
CHARLES A. KING TRUST POSTDOCTORAL RESEARCH FELLOWSHIP PROGRAM: Apply NOW for the 
2019 Postdoctoral Research Fellowship Program in the Basic Sciences and Clinical/Health Services 
Research.  The primary goal is to provide fellowships to Massachusetts’ postdoctoral fellows to 
investigate the causes of diseases in human beings, and/or improve methods of treatment for human 
diseases.  US citizenship is not required.   
 
Eligibility:  
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Basic Science: By September 1, 2019, applicants must have completed a minimum of three years, but not 
more than five years, of full-time postdoctoral research. For more information about the Basic Science 
program, click here. 
 
Clinical/Health Services Research: By September 1, 2019, applicants must have no more than five years 
of employment since completion of residency training or three to five years of postdoctoral employment. 
For more information about the Clinical/Health Services program, click here. 
 
Application Deadline: March 1, 2019 by 3:00pm EST 
Award Amount: Two-year grants from $104,008 to $117, 760 total 
Funding Period: September 1, 2019 through August 31, 2021 
 
For further information or questions, contact Lindsey Phelan, Grants Office, at LPhelan@hria.org. 
 
 
 
CIMIT FUNDING: The Consortia for Improving Medicine with Innovation and Technology, in partnership 
with TRISH (Translational Research Institute for Space Health at Baylor University) announces eight (8) 
new solicitation opportunities aimed at protecting and optimizing human health and performance during 
long-duration space exploration missions.  Companies with existing medical products, or those still in 
development, may be awarded up to $250k to augment ongoing development efforts.  TRISH’s funds can 
be used to advance the development and make a product viable for use in long-duration space flight (e.g. 
by miniaturizing, reducing power and/or packaging, simplifying use, extending shelf life, etc.) which will 
also make it a more robust and successful commercial product.  This is a rapid response and unique 
opportunity to send your device to space.  Notification by February 15, 2019.  To learn more, contact 
Dr. Steve Schachter at CIMIT (sschacht@bidmc.harvard.edu) or click here.  
 
 
DRIVe’s EZ-BAA APPLICATION PROCESS:  Is now open for business!  Calling all medical product 
developers, research teams, and companies! Those offering disruptive innovative approaches that will 
transform health security threats are now invited to submit abstracts using DRIVe’s simplified EZ-BAA 
process.  Applications must offer transformative innovation, products, and technologies to protect 
Americans from health security threats.  
 
In-scope priority areas include: 
• Products and solutions to reduce illness and death from sepsis as part of DRIVe’s Solving Sepsis Initiative; 
• Technologies and processes to identify infections and exposures to biological and other health threats, as outlined in the Early 
Notification to Act, Control, and Treat (ENACT) initiative; and 
• Tools and techniques to mitigate the damages and loss of life associated with catastrophic events 
 
Download the DRIVe EZ-BAA abstract submission application, click here. 
To learn more about the DRIVe EZ-BAA, click here. 
 
 
GROWING GENE AND CELL THERAPY (GGACT) RFA WINTER: The GGACT cooperative, a collaboration 
between Boston Children’s Hospital, Cincinnati Children’s Hospital Medical Center, and the University of 
California Los Angeles, was established to support investigators in rapidly translating complex gene and 
cell therapies to early phase, investigator-initiated clinical trials by providing expertise in protocol 
development and implementation, trial and data management, and regulatory affairs, as well as utilizing 
established infrastructure for preclinical models of disease and testing, process development, and GMP 
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vector production and cellular manufacturing.  More information on GGACT can be found at 
www.GGACT.org.  
 
Eligible applicants must be faculty at a CTSA institution that has an established pediatric stem cell 
transplant program.  For more information, contact Maria Suarez (maria.suarez@childrens.harvard.edu).  
Invited full applications will be due March 22, 2019. 
 
 
IMMUNO-ONCOLOGY TRANSLATION NETWORK (IOTN): OPPORTUNITY ONE (Cancer 
Immunoprevention Research Projects (U01 Clinical Trial Not Allowed)) The NIH has released two new 
FOAs associated with Beau Biden Cancer Moonshot Initiative intended to accelerate cancer research.  
Specifically, these FOAs seek to support the creation of a translational science network devoted 
exclusively to immunotherapy approached to treat and prevent adult cancers.  Applications to RFA-CA-
19-014 and RFA-CA-19-015 are due by Friday, February 8, 2019 5pm EST. To learn more about Cancer 
Moonshot, click here. 
 
OPPORTUNITY TWO (Cancer Immunoprevention Research Projects UG3/UH3): The purpose of this FOA, 
associated with the Beau Biden Cancer Moonshot Initiative, is to support UG3/UH3 Cancer 
Immunoprevention Phased Award Projects.  Applicants responding to this FOA must apply for both the 
UG3 and UH3 phases together in a single application.  Applications are due Monday, February 11, 2019 
by 5pm EST.  To learn more, click here. 
 
OPPORTUNITY THREE (Immuno-engineering to Improve Immunotherapy (i3) Centers (U54 Clinical Trial 
Not Allowed)): The purpose of this FOA is to develop immune-engineering to improve immunotherapy 
(i3) centers, as new components of the IOTN.  The i3 centers will be comprised of multi-disciplinary 
teams focused on developing and employing engineered immunotherapy approached to design more 
durable, widely accessible, and less toxic immunoprevention and immunotherapy strategies.  
Applications are due Monday, February 11, 2019 by 5pm EST. To learn more, click here. 
 
 
MCCISS K12 TRAINING GRANTS: The Massachusetts Consortium for Cardiopulmonary Implementation 
Science Scholars (MCCISS) announces K12 training grants for 2019.  
 
MCCISS Important Dates:  
02.25.2019 Full Applications due 
04.01.2019 Scholar Selection 
09.01.2019 Scholar Appointments 
 
For more information, please visit www.umassmed.edu/mcciss/ 
 
The Massachusetts Consortium for Cardiopulmonary Implementation Science Scholars is supported by  
the National Heart, Lung, And Blood Institute of the National Institutes of Health under Award Number K12HL138049. 
 
 
NCATS FUNDING: NCATS has announced funding opportunities to use partially developed therapeutic 
candidates to identify new treatments for a broad range of diseases. For full details, click on this link: 
https://ncats.nih.gov/news/releases/2018/ntu-foa-2018 
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NEW: NIH POINT-OF-CARE TECHNOLOGY RESEARCH NETWORK (POCTRN): POCTRN drives the 
development of point-of-care technologies through collaborative efforts that merge scientific and 
technological capabilities with clinical need.  The goal is to develop technological with clinical 
applications using a network model that enhances complementary strengths and builds multidisciplinary 
partnerships.  With the recent announcement of a $7.9 million grant from the NIH, UMMS and M2D@ are 
poised to establish a new POCTRN site: Center for Advancing Point-of-Care Technologies (CAPCaT) in 
Heart, Lung, Blood, and Sleep Disorders.  Apply to CAPCaT now for funding here.  Expressions of Interest 
are due March 1, 2019.  For more information on POCTRN, click here and here. 
 
 
NEW: CUREACCELERATOR LIVE! Two Funding Opportunities: (1) Repurposing Research Funding 
Announcement Funds Available for Rare Disease Clinical Repurposing Research Trials. Up to $50k 
funding available for rare disease repurposing clinical trials, proposals due by 02.28.2019.  
Eligible submissions can come from North America and Europe.  Five finalists to be selected to pitch their 
repurposing clinical trials at the 2019 Spring/Summer CureAccelerator Live! Event.  For more info, click 
here.  Submit proposals here.  
 
(2) Repurposing Research Funding Announcement Funds Available for Developing World Clinical 
Repurposing Research Trials.  Up to $50k funding available for any disease that primarily impacts 
patients in the developing world, proposals due by 02.14.2019.  Eligible submissions can come from 
research institutions located anywhere in the world, including upper-middle and high-income countries 
(applicants based in developing countries will be given a higher ranking in the review process).  Five 
finalists will be selected to present at the Live! Event in the Boston area.  For more info, click here.  
Submit proposals here. 
 
 
 
EDUCATION 
 
~ NEW: HARVARD CATALYST COURSE: Introduction to Translational Medicine April 8-11, 2019 
~ K CLUB 
~ PiPSS (Projects in Process Seminar Series) February 7 and February 21, 2019  
~ ISSR Methodology Workshops (Spring 2019 / multiple dates)  
 
 
NEW: HARVARD CATALYST COURSE:  Introduction to Translational Medicine – a four-day survey 
course is being offered on April 8-11, 2019.  This course is an introduction to the principles and practice 
of T1 translational research utilizing both case studies and a didactic curriculum and will explore the 
skills necessary to embark on a career in translational research, particularly in the process of bringin an 
idea from the laboratory to first-in-human trials (called T1 translational research).  Eligibility is MD, 
DMD, PharmD, DNP, PhD, or equivalent with involvement in basic or clinical research.  Application 
deadline is February 27, 2019.  To learn more or register, click here. 
 
 
K CLUB: Meets every 1st and 3rd Wednesday from 4:00pm to 5:00pm in S2-160 to provide information 
and feedback on Research Career Award applications (NIH K Awards, VA Research Career Awards, CTSA 
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K grants, etc). Participants receive feedback on their biosketch, training plans, research plan, specific 
aims, and a wealth of other information.   
 
For more information, visit: https://www.umassmed.edu/ccts/education/k-club 
 
 
PiPSS: The Projects in Process Seminar Series (PiPSS) is designed to give CCTS trainees and junior faculty 
an opportunity to present their work in a structured format and in a forum of peers and faculty, with the 
goal of ensuring continuous, professional feedback and cross-fertilization that is required for excellence 
in research.  Sessions are held monthly on the 1st and 3rd Thursdays of each month – October 18, 
2018 through May 2, 2019 beginning at 3:30pm in ASC8.2072 (Albert Sherman Building). 
 
February 7th presentations: 
 
→ Ameer Elaimy, MD/PhD “Role of Autocrine VEGF Signaling in Breast Cancer Stem Cell Function 
and Chemotherapy Resistance” 
 
→ Michael Frisoli, MD/PhD “Innate Immune Contributions to Vitiligo” 
 
→ Katelyn McCann, MD/PhD “Regulation and Function of IRG1 and Itaconate in the Human Innate 
Immune Response” 
 
→ Ankur Sheel, MD/PhD “Depletion of TRRAP Induces p53-Independent Senescence in Live Cancer by 
Inducing Mitotic Catastrophe” 
 
February 21st presentations: 
 
→ Michelle Trivedi, K “Aligning Stakeholder Agendas in the Refinement of the Asthma Link Protocol: 
Real World Implementation of School-Supervised Asthma Therapy” 
 
→ Paul Greer, K “Exteroceptive and Interoceptive Chemosensation by MS4A Receptors” 
 
→ Dominic Gessler, Millennium “Canavan Disease Gene Therapy: From Mouse to Human to Basic 
Biology” 
 
→ Noah Silverstein, MD/PhD “Epigenetic Inheritance in a Mouse Model of Influenza Infection” 
 
 
NEW: ISSR METHODOLOGY WORKSHOPS / SPRING 2019: New classes being offered in Amherst this 
spring (see list below).  For more information or to register, click here. 
 
• Stata for Beginners: Tuesday February 12 from 10am to 12pm 
• Getting Started in NVivo: The Basics (Session 1), Wednesday February 13 from 10am to 12pm 
• How to Do Network Analysis: Wednesday February 13 from 12:30 pm to 2:15pm 
• Introduction to Questionnaire Design: Thursday February 14 from 2pm to 5pm 
• Introduction to SPSS: Monday February 25 from 2pm to 4pm 
• Regression Analysis Using Stata: Tuesday February 26 from 10am to 12pm 
• Using NVivo Queries to Explore Your Data: Wednesday February 27 from 10am to 12pm 
• Introduction to SAS: Data Management: Thursday February 28 from 2pm to 4pm 
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EVENTS 
 
~ UPDATE: 8th Annual UMCCTS Community Engagement and Research Symposium Call for Posters 
~ NEW: 14th Annual Texas Conference on Health Disparities June 6-7, 2019 
~ NEW: Cancer Biology Program Research Retreat February 13, 2019 Call for Speakers/Posters 
~ The Opioid Crisis and the Future of Addiction and Pain Therapeutics: Opportunities, Tools and 
Technologies, February 7-9, 2019 
~ NEW: Program in Molecular Medicine Seminar Series: Cholsoon Jang, PhD February 21, 2019 
~ NEW: TS19 Washington DC March 5-8, 2019 
~ NEW: Un-Meeting on Rural Health and Health Equity April 8, 2019 
~ NEW: NIH POCTRN Webinar February 26, 2019 (Speaker: James Stahl) 
 
 
8th ANNUAL UMCCTS COMMUNITY ENGAGEMENT AND RESEARCH SYMPOSIUM: Friday, March 22, 
2019 (8:15am-1:30pm), UMass Medical School Albert Sherman Center, Worcester MA.  The goals of the 
UMCCTS Community Engagement and Research Symposium is to build our shared capacity to address 
health issues in communities throughout the Commonwealth by helping attendees: (1) network; (2) learn 
more about each other’s work/interests; and (3) make connections and plan for future collaborative 
work.  
Keynote: 
Mona N. Fouad, MD, MPH, Senior Associate Dean, Diversity and Inclusion 
University of Alabama at Birmingham. 
 
Registration opens on January 7, 2019  
Visit our website to learn more: https://www.umassmed.edu/ccts/community 
 
Notification Date: The deadline to submit posters has passed.  If you did submit a poster and it is 
accepted, you will receive notification by February 15, 2019. 
 
Questions?  Email communityengagement@umassmed.edu. 
For more information, visit www.umassmed.edu/ccts/community 
 
 
NEW: 14th ANNUAL TEXAS CONFERENCE ON HEALTH DISPARITIES: June 6-7, 2019. “Social 
Epigenomics & Health Disparities.” Evidence based approaches that identify mechanisms by which social 
experiences at various stages of life, both positive and negative, affect gene function and thereby 
influence health in racial/ethnic minority and health disparity population.  The conference will feature 
nationally renowned speakers and will highlight evidence-based clinical, community and policy 
approaches to improving maternal and child health across the United States.  To learn more, click here. 
 
 
NEW: CANCER BIOLOGY PROGRAM RESEARCH RETREAT (Call for Speakers and/or Posters): 
February 13, 2019 8:30am-5:00pm.  Please join us for an all-day research retreat hosted by the UMMS 
Cancer Biology Program to be held at College of the Holy Cross, Hogan Center Ballroom, 1 College Street, 
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Worcester MA 01610. Keynote speaker is Dr. Kornelia Polyak of the Dana Farber Cancer Institute, along 
with talks by various UMMS faculty, post-docs and graduate students, and a poster session.  If you are 
interested in speaking at this event or in presenting a poster, please click here for further 
information. 
 
 
THE OPIOID CRISIS AND THE FUTURE OF ADDICTION AND PAIN THERAPEUTICS: Opportunities, 
Tools and Technologies: February 7-8, 2019, Kirschstein Auditorium, Natcher Conference Center, NIH 
Campus, Bethesda MD. Speakers include Nora Volkow, George Koob, Frances Collins, Eric Nestler, Paul 
Kenny, Garret Stuber, Michael Bruchas, Clifford Woolf, Brigette Kieffer, Peter Kalivas, Ron Dror.   
 
For more information, click here. 
 
 
NEW: MOLECULAR MEDICINE SPECIAL SEMINAR: Cholsoon Jang, PhD “Illuminating Nutrient 
Metabolism with In Vivo Isotope Tracing and Metabolomics.” Thursday, February 21, 2019 at 
4:00pm – Molecular Medicine Seminar Room 3rd Floor, Biotech Two.  Hosted by Roger J. Davis PhD 
508.856.6054. 
 
 
NEW: TS19 WASHINGTON DC: The premiere translational science meeting of the year will be held in 
Washington DC on March 5-8, 2019.  Come network and learn from researchers of all skill sets and 
experience levels across the clinical and translational science spectrum.  To learn more, click here.  
 
 
NEW: UN-MEETING ON RURAL HEALTH AND HEALTH EQUITY: Monday, April 8, 2019 in Gainesville 
FL. This event focuses on catalyzing new collaborations to bridge the translational science and 
agricultural extension sectors to improve rural health and achieve health equity.  An evening welcome 
reception on Sunday, April 7 will precede the Un-Meeting.  More details coming early 2019! 
 
Hosted by the University of Florida Clinical and Translational Science Institute  
and the University of Florida Institute of Food and Agricultural Sciences. 
 
 
NEW: NIH POCTRN WEBINAR February 26, 2019, 2:00pm EST Speaker: James Stahl MD, CM, MPH, 
Health Researcher, Dartmouth-Hitchcock Medical Center and Massachusetts General Hospital will 
provide relevant information on how a Systems Engineering approach to developing disruptive point-of-
care technologies can help overcome the many barriers to successful clinical adoption.  To register for this 
webinar, click here. 
 
 
DID YOU KNOW? 
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CTSA Regulatory Expertise: Three North Carolina Clinical and Translational Science Awards (CTSA) 
Program hubs have collaborated to create a platform for sharing regulatory expertise and best practices. 
The Regulatory Guidance for Academic Research of Drugs and Devices (ReGARDD) Program provides 
researchers with regulatory guidance, education, and consultative support, to ultimately help them move 
promising products and novel discoveries to clinical trials. 
  
ReGARDD, which is coordinated by Duke University, the Wake Forest School of Medicine, and the 
University of North Carolina at Chapel Hill hubs with partner RTI International, officially launched in 
2015 and has been developing since. The program builds upon the existing services and knowledge of the 
North Carolina CTSA Program Regulatory Groups and the Research Triangle Park (RTP). 
 
Read the full story here.  Visit the ReGARDD website here. 
 
 
DIAMOND PORTAL: To address the need for consistent training assessment and measures of 
competency, the Michigan Institute for Clinical & Health Research (MICHR) has collaborated with the 
Ohio State University, Rochester University, and Tufts University to launch the DIAMOND Portal. It is a 
pioneering digital collection that serves as a sustainable, federated database for members of clinical and 
translational research study teams to share and access training and assessment resources. For more 
information, visit https://www.michr.umich.edu/news/2018/10/15/new-diamond-portal-allows-ctsa-
members-to-access-share-training-and-assessment-materials 
 
 
HRPP QA/QI: The Human Research Protection Program (HRPP) Quality Assurance/Quality 
Improvement (QA/QI) Program is a component of the UMass Center for Clinical and Translational 
Science. The program is independent of the IRB and helps study teams and investigators by conducting 
routine post-approval monitoring of on-going research to evaluate adherence with institutional 
requirements and federal regulations. If there are review findings, the QA/QI manager shares those 
findings with investigators and study teams, and provides direct education on the findings, including how 
to avoid making similar errors in the future. In order to support improvement at an institutional level, the 
QA/QI manager shares aggregated data from reviews with the HRPP leadership and the Research 
Community to identify trends and target areas for education. The program also makes self-evaluation 
tools available to investigators and study teams seeking to perform their own assessments.  To learn 
more about HRPP QA/QI HRP-142, visit: https://www.umassmed.edu/globalassets/ccts/ccts-
media/irb/updated-sops-2015/hrp-142-hrpp-qa-qi-program-final.pdf. 
 
 
NATIONAL CENTER FOR DATA TO HEALTH (CD2H): The goal of CD2H is to make data more 
meaningful, open and accessible. The CD2H supports a vibrant and evolving collaborative informative 
ecosystem for the CTSA program and beyond. The CD2H harnesses and expands an ecosystem for 
➢ CTSA Regulatory Expertise 
➢ Diamond Portal Allows CTSA Members to Access 
➢ HRPP QA/QI 
➢ National Center for Data to Health (CD2H) 
➢ Recruitment and Retention Toolkit 
➢ UMCCTS Intake Portal 
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translational scientists to discover and share their software, data and other research resources within the 
CTSA program network.  The CD2H also creates a social coding environment for translational science 
institutions, leveraging the community-driven DREAM challenges as a mechanism to stimulate 
innovation. To learn more, click here. 
 
 
RECRUITMENT AND RETENTION TOOLKIT: The Trial Innovation Network accepts toolkit submissions 
from CTSAs and reputable community health partners and provides them as a free resource to the 
research community.  The materials on this site are designed primarily for CTSA program staffs. These 
resources are intended to provide a variety of information that includes best practices and evidence-
based recruitment and retention strategies. Full information can be found at 
https://trialinnovationnetwork.org/recruitment-retention-toolkit/?key-element=1681 
 
 
UMCCTS INTAKE PORTAL: The UMass Center for Clinical and Translational Science has implemented an 
intake/service request portal. Currently the portal is being utilized by the Office of Clinical Research for 
intake of all agreements and amendments. OnCore updates/corrections and Certificates of 
Confidentiality. The portal can be accessed on their newly updated website at 
https://www.umassmed.edu/ocr/ 
 
 
 
SHARE YOUR SUCCESS STORY 
Have you had your research published that cites the UMass Center for Clinical and Translational Science?  
Has your patent been filed on technology developed using Center funding or resources? Did your pilot 
project receive external grant funding? Share it with us at ccts@umassmed.edu. Sharing your success 
demonstrates the importance and effect of the Center for Clinical and Translational Science at UMass. 
 
 
 
 
Newsletter Submissions: To be included in the CCTS Monthly Newsletter, please send announcements, 
including a link, to ccts@umassmed.edu.  The newsletter is published the first week of each month. 
 
CITE: UMCCTS funded by NCATS:  
Cite grant UL1TR001453, TL1TR001454, and KL2TR001455 
in all presentations and journal publications. 
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